A completely new review from The purpose job and KORFOR reveals that the use of the robust agony-relieving opioid oxycodone has substantially elevated in Norwegian hospitals and primary healthcare products and services in the last 10 years. The examine continues to be printed during the European Journal of Agony.
Another important discovering is the fact typical practitioners are to blame for approximately ninety% of opioid prescriptions in Norway.
News > 2025 > Oxycodone use is increasing both equally in hospitals and first care Oxycodone use is raising each in hospitals and first treatment
Det er ingen nasjonale norske retningslinjer som anbefaler legene å bruke morfin fremfor oksykodon. Norsk legemiddelhåndbok anbefaler morfin ved valg av sterke opioidagonister.
S. and should be connected to a greater hazard of dependence and overdose, In line with current experiments. In Norway, the advice is to make use of morphine as the initial preference.
Opioid use declined in Denmark and Sweden—in both 1-year person prevalence and volumes of MMEs—though stabilizing in Norway. Norway continuously experienced a greater and stable prevalence of opioid end users. Denmark led in whole amounts of MMEs dispensed, possible because of extra Regular morphine and oxycodone use, Whilst Norway ranked optimum in DDDs.
– Vi sitter på ganske mye registermateriale og skal identifiserer de som bruker opioider rapid. Så vil se om og eventuelt når de startet med adjuvante analgetika og om og det bidrar til mindre bruk av opioider på sikt.
In addition, metric-dependent variation underscores the necessity for working with multiple complementary metrics to properly interpret opioid utilization developments.
Oksykodon var sentral i utviklingen av opioidepidemien i United states of america og kan være assosiert med høyere risiko for avhengighet og overdose ifølge nyere studier1. I Norge er det anbefalt å bruke morfin som fileørstevalg blant sterke opioider2.
Det ble observert en moderat samvariasjon mellom bruk på sykehus og forskrivning i primærhelsetjenesten. Anbudsavtaler for morfin på sykehus gikk ned med 80 prosent i perioden, mens avtalene for oksykodon forble stabile.
Fastlegene har den fulle bredde av pasienter – også de pasientene som ikke fikk god nok smertelindring på sykehus. Males forskjellene mellom sykehusleger og fastleger kan gå begge veier når det gjelder forskriving, understreker Haarr, som selv er allmennlege ved Byhaugen legesenter i Stavanger to dager i uken.
Outcomes Clinic oxycodone use elevated by sixty seven.0% and first treatment prescribing rose by 86.five%. Morphine use amplified by twelve.six% in hospitals but decreased by 23.two% in Key care. A average covariation (Pearson's r = 0.48) in between healthcare facility use and primary treatment prescribing was observed. Healthcare facility tender agreements for morphine declined by 80%, though All those for oxycodone remained secure. Conclusions Oxycodone use considerably increased relative to morphine in Norwegian hospitals and first treatment. Prescription styles demonstrate reasonable covariation, suggesting a potential connection concerning clinic and primary care prescribing, nevertheless causality continues to be unsure. Tender agreements may add to prescribing trends in hospitals, with achievable associations in Principal treatment. Significance This research is the first to deliver quantitative proof of covariation concerning in-medical center use and first treatment opioid prescribing throughout a countrywide Health care program. Even with suggestions favoring morphine, oxycodone prescribing continues to increase in Norway, with marked geographical variation. By linking procurement knowledge, prescription styles and tender agreements, our findings highlight the necessity to contemplate healthcare facility practices and structural things when addressing opioid prescribing. These final results give new insights into prospective levers for opioid stewardship throughout treatment concentrations.
Det ble mottatt sixty one svar, responsraten var 32 %. Fastlegene besvarte spørsmålene ut fra én konkret pasient de hadde søkt refusjon for. Resultater: Gjennomsnittlig dosering per dag var 76 mg orale morfinekvivalenter (OMEQ). Samtidig bruk av legemidler fra reseptgruppe A eller B i tillegg til opioider forekom hos 53 % (n = 31) av pasientene. I gruppen der pasienten hadde slik samtidig bruk var 41 % (n = 13) av fastlegene enig eller delvis enig i at den medikamentelle behandlingen var hensiktsmessig. I gruppen der pasienten kun brukte opioider, mente 72 % av fastlegene det samme. Konklusjon: Ordningen med individuell refusjon av opioider på blå resept mot langvarige smertetilstander er ingen click here garanti for at pasienten er sikret forsvarlig eller hensiktsmessig medikamentell behandling.
Scientists have analyzed the tendencies in the usage of morphine and oxycodone from 2010 to 2021. Additionally they investigated irrespective of whether variations in the usage of both of these substances in hospitals can be relevant to developments in Principal healthcare.